Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1β

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 3, 1999, Pages 616-622

  Kishi, Kenji ^a   Hirai, Kazuhiro ^a   Hiramatsu, Kazufumi ^a   Yamasaki, Tohru ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CEFTAZIDIME; CLINDAMYCIN; ENDOTOXIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; LIMULUS LYSATE TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SEPTICEMIA;

EID: 0033018976     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.3.616     Document Type: Article

References (32)

1. Boe, N. M., E. P. Dellinger, and B. H. Minshew. 1983. Effect of clindamycin on growth and haemolysin production by Escherichia coli. J. Antimicrob. Chemother. 12(Suppl. C):105-116.
2. Bone, R. C. 1993. Gram-negative sepsis: a dilemma of modern medicine. Clin. Microbiol. Rev. 6:57-68.
3. Dofferhoff, A. S. M., J. H. Nijland, H. G. de Vries-Hospers, P. O. M. Mulder, J. Weits, and V. J. J. Bom. 1991. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand. J. Infect. Dis. 23:745-754.
4. Dofferhoff, A. S. M., M. T. Esselink, H. G. de Vries-Hospers, A. V. Zanten, V. J. J. Bom, J. Weits, and E. Vellenga. 1993. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumor necrosis factor by human monocytes. J. Antimicrob, Chemother. 31:373-384.
5. Fealon, D. T., S. Ruddy, P. H. Schur, and W. R. McCabe. 1975. Activation of the properdin pathway of complement in patients with gram-negative bacteremia. N. Engl. J. Med. 292:937-940.
6. Homma, J. Y., M. Matsuura, and Y. kumazawa. 1990. Structure-activity relationship of chemically synthesized nonreducing parts of lipid A analogs. Adv. Exp. Med. Biol. 256:101-119.
7. Ikeda, T., T. Sakai, K. Kikuchi, and T. Mizuwatari. 1985. Concentration of clindamycin phosphate in lung tissue. Jpn. J. Antibiot. 38:3477-3480.
8. Jackson, J. J., and H. Kropp. 1992. Beta-lactam antibiotic-induced release of endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2 specific imipenem and PBP-3 specific ceftazidime. J. Infect. Dis. 165:103-141.
9. Kimball, H. R., K. L. Melmon, and S. M. Wolff. 1972. Endotoxin-induced kinin production in man. Proc. Soc. Exp. Biol. Med. 139:1078-1082.
10. Kirikae, T., M. Nakano, and D. C. Morrison. 1997. Antibiotic-induced endotoxin release from bacteria and its clinical significance. Microbiol. Immunol. 41:285-294.
11. Kuga, H. 1987. High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes. Antimicrob. Agents Chemother. 31:1904-1908.
12. Kotani, S., and H. Takada. 1990. Structural requirements of lipid A for endotoxicity and biological activities: an overview. Adv. Exp. Med. Biol. 256: 13-43.
13. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318:1481-1486.
14. Molina, J., D. T. Scadden, R. Bym, C. A. Dinarello, and J. E. Groopman. 1989. Production of tumor necrosis factor-alpha and interleukin 1-beta by monocytic cells infected with human immunodeficiency virus. J. Clin. Invest. 84:733-737.
15. Mori, K. 1993. Influence of antibiotics on IgG production by cultured human lymphocytes. Kurume Med. J. 56:1314-1326.
16. Morrison, D. C., S. E. Bucklin, and M. Norimatsu. 1996. Contribution of soluble endotoxin released from gram-negative bacteria by antibiotics to pathogenesis of experimental sepsis in mice. J. Endotoxin Res. 3:237-243.
17. Morrison, D. C., and J. L. Kyan. 1987. Endotoxin and disease mechanisms. Annu. Rev. Med. 38:417-432.
18. Nakano, M., H. Asou, and I. Yamamoto. 1975. Stimulation of phagocytic activity in the reticuloendothelial systems of mice by lipid A complexed with homologous or heterologous proteins. Infect. Immun. 11:592-594.
19. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Nies, A. S., R. P. Forsyth, H. E. Williams, and K. L. Melmon. 1968. Contribution of kinins to endotoxin shock in unanesthetized rhesus monkeys. Circ. Res. 22:155-164.
21. Ras, G. J., R. Anderson, G. W. Taylor, J. E. Savage, E. van Niekerk, G. Joone, H. J. Koornhof, J. Saunders, R. Wilson, and P. J. Cole. 1992. Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro. Antimicrob. Agents Chemother. 36:1236-1240.
22. Reilly, J., A. Compagnon, P. Tournier, and H. D. Buit. 1950. Les accidents du traitment des fievres typhoides par la chloromycetine. Ann. Med. (Paris) 51: 597-629.
23. Sands, K. E., D. W. Bates, P. N. Lanken, et al. 1997. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278:234-240.
24. Santos, J. I., A. Arbo, and N. Pavia. 1992. In vitro and in vivo effects of clindamycin on polymorphonuclear leukocyte function. Clin. Ther. 14:578-594.
25. Simon, D. M., G. Koenig, and G. M. Trenholme. 1991. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J. Infect. Dis. 164:800-802.
26. Stevens, D. L., A. E. Bryant, and S. P. Hackett. 1995. Antibiotic effects on bacterial viability, toxin production, and host response. Clin. Infect. Dis. 20(Suppl. 2):154-157.
27. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
28. Ulevitch, R. J., C. G. Cochran, P. M. Henson, D. C. Morrison, and W. F. Doe. 1975. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. 1. The role of complement. J. Exp. Med. 142:1570-1590.
29. Veringa, E. M., D. W. Lambe, Jr., D. A. Ferguson, Jr., and J. Verhoel. 1989. Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentration. J. Antimicrob. Chemother. 23:577-587.
30. Veringa, E. M., and J. Verhoef. 1987. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus. Chemotherapy 33:243-249.
31. Wolf, S. M. 1973. Biological effects of bacterial endotoxins in man. J. Infect. Dis. 128(Suppl.):259-264.
32. Young, L. S. 1990. Gram-negative sepsis, p. 611-636. In G. L. Mandell, R. G. Douglas, Jr., and J. E. Benett (ed.). Principles and practice of infectious disease, 3rd ed. Churchill Livingstone, New York, N.Y.